Fennec Pharmaceuticals Inc.
FENC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $27 | $13 | $24 | $21 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $13 | $9 | $2 | $0 |
| Inventory | $1 | $2 | $1 | $0 |
| Other Curr. Assets | $4 | $3 | $1 | $1 |
| Total Curr. Assets | $44 | $27 | $27 | $22 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $0 | $0 |
| Total NC Assets | $1 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $45 | $27 | $27 | $22 |
| Liabilities | – | – | – | – |
| Payables | $3 | $4 | $2 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $4 | $2 | $1 |
| Total Curr. Liab. | $7 | $8 | $5 | $2 |
| LT Debt | $19 | $31 | $25 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $25 | $0 | $0 | $0 |
| Total NC Liab. | $44 | $31 | $25 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $51 | $38 | $30 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $146 | $144 | $143 | $141 |
| Retained Earnings | -$220 | -$219 | -$203 | -$179 |
| AOCI | $1 | $1 | $1 | $1 |
| Other Equity | $67 | $62 | $57 | $53 |
| Total Equity | -$6 | -$12 | -$3 | $16 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $45 | $27 | $27 | $22 |
| Net Debt | -$7 | $18 | $1 | -$16 |